1. Home
  2. QTRX

as of 12-26-2025 4:00pm EST

$6.46
$0.16
-2.42%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Founded: 2007 Country:
United States
United States
Employees: N/A City: BILLERICA
Market Cap: 352.7M IPO Year: 2017
Target Price: $11.33 AVG Volume (30 days): 654.8K
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.36 EPS Growth: N/A
52 Week Low/High: $4.05 - $12.41 Next Earning Date: 11-10-2025
Revenue: $130,203,000 Revenue Growth: -2.69%
Revenue Growth (this year): -1.16% Revenue Growth (next year): 28.28%

AI-Powered QTRX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 80.26%
80.26%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Quanterix Corporation News

QTRX Breaking Stock News: Dive into QTRX Ticker-Specific Updates for Smart Investing

All QTRX News

Share on Social Networks: